RIGL
Rigel Pharmaceuticals Inc
47.90$
-0.5%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -87.2% | -87.7% | -104.4% | -218.7% | -293.4% | -806.1% | -212.8% | -107.1% | -414.3% | – | -13,703.9% | 37.4% | -1,460.5% | -3,786.3% | -1,203.7% | -845.5% | -81.0% | -372.3% | -1,729.6% | -132.2% | -70.0% | -48.0% | 3.9% | -61.3% | -4.9% | 17.6% | 25.7% | |
| 21.2% | 57.2% | 44.2% | 36.9% | 28.7% | 50.1% | 7.1% | 4.2% | 10.7% | – | 187.1% | 1.1% | 41.2% | 108.1% | 36.3% | 28.6% | 5.0% | 4.6% | 10.4% | 1.3% | 1.2% | 0.6% | 0.8% | 0.8% | 1.1% | 1.2% | 0.8% | |
| – | 36.9% | 17.2% | 6.1% | 4.6% | 2.7% | 0.2% | 37.6% | 92.8% | – | 1,791.7% | 13.1% | 277.2% | 560.8% | 100.2% | 118.6% | 25.6% | 36.0% | 133.5% | 17.3% | 15.4% | 6.7% | 6.4% | 10.3% | 7.5% | 6.9% | 4.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | 277.2% | 560.8% | 100.2% | 117.4% | 25.4% | 39.6% | 117.2% | 17.3% | 15.4% | 6.7% | 8.7% | 10.9% | – | – | – | |
| 10.4% | -9.2% | 10.3% | -19.9% | 42.2% | 280.2% | 66.7% | -36.4% | 71.7% | – | -809.7% | -7.1% | 31.1% | -62.3% | -95.0% | -2.4% | 66.7% | -77.5% | -121.1% | 9.3% | 28.1% | -27.9% | 6.5% | -24.2% | 8.1% | 0.1% | -6.6% | |
| 78.9% | 27.4% | 21.1% | 10.4% | 11.2% | 32.6% | 10.9% | 2.7% | 7.4% | – | 18.8% | 2.8% | 48.5% | 150.1% | 17.1% | 5.0% | 1.9% | 3.9% | 3.7% | 2.5% | 2.5% | 1.2% | 0.4% | 0.4% | 12.8% | 0.2% | 0.0% | |
| -78.9% | -57.3% | -138.2% | 123.5% | -337.5% | -545.2% | -13.0% | 11.8% | -61.8% | – | -4,088.5% | -42.7% | -1,323.1% | -1,735.6% | 1,012.3% | 762.8% | 154.4% | 122.1% | -434.3% | 56.1% | -39.9% | 43.7% | -53.6% | 60.5% | -3.7% | 2.3% | -31.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | 3,005.9% | 6,182.0% | 14.7% | 14.2% | 24.4% | 123.6% | 2,624.6% | 161.5% | 2.7% | 2.4% | 3.2% | 1.8% | 0.0% | -5.6% | 0.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | -16.8% | – | – | – | – | 48.0% | 218.3% | 22.0% | 16.5% | 9.2% | 13.1% | 16.3% | 17.1% | 0.0% | -2.5% | |
| 125.3% | 471.8% | -2.7% | 190.5% | 477.9% | 1,369.8% | 626.9% | 8.5% | 450.6% | – | 13,620.7% | 0.7% | 2,989.0% | 6,182.0% | 14.7% | 14.2% | 24.4% | 123.6% | 2,624.6% | 161.5% | 19.2% | 11.6% | 42.0% | 5.4% | 15.7% | -6.5% | 0.2% | |
| -40.7% | 326.8% | -245.3% | 95.3% | -153.0% | 18.5% | 401.1% | -86.8% | -25.6% | – | -4,171.7% | -4.7% | 205.4% | 660.0% | -176.6% | -68.5% | 97.8% | -126.7% | 460.7% | 85.4% | -90.7% | 7.2% | -7.7% | 4.6% | 7.1% | 13.4% | -5.5% | |
| -166.0% | -115.0% | -125.5% | -229.1% | -304.7% | -838.7% | -223.7% | -109.8% | -421.7% | – | -13,722.7% | 34.5% | -1,509.0% | -3,936.4% | -1,220.7% | -850.5% | -82.9% | -376.3% | -1,733.3% | -134.7% | -72.5% | -49.2% | 3.5% | -61.7% | -17.7% | 17.3% | 25.7% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.